Skip to Content

UIHC one of 120 sites testing new Pfizer COVID-19 vaccine

IOWA CITY, Iowa (KWWL) - Researchers for University of Iowa Health Care hope to enroll 250 healthy adults to test a new RNA vaccine made by Pfizer in the fight against COVID-19. UIHC is one of roughly 120 sites testing the vaccine.

The research team, led by Dr. Patricia Winokur, is looking for men and women age 18-85 with stable health and who work in essential jobs like food production or health care.

Patients will get an injection deep into their muscle tissue either three weeks or two months apart, according to Winokur, and will be evaluated over the course of six visits. Half of the participants will get a placebo and half will get the real drug.

The team will be monitoring the safety and tolerability of the drug in patients as well as the type of immune system response that it generates. BioNTech SE and Pfizer are conducting the study worldwide, which will have roughly 30,000 total volunteers.

Travis Breese

Reporter, Iowa City

Skip to content